Herantis Pharma (OHEL:HRTIS) OCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OHEL:HRTIS Herantis Pharma PLC OHEL:HRTIS
26 GF Score
Price €1.63
! 3 Warning Signs
View Full Analysis

What is Herantis Pharma OCF Margin %?

Herantis Pharma OHEL:HRTIS +4.49% 26 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates OHEL:HRTIS with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 953 Biotechnology companies, Herantis Pharma ranks worse than 104931.69% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Herantis Pharma's Cash Flow from Operations for the six months ended in Dec. 2025 was €-2.71 Mil. Herantis Pharma's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Herantis Pharma's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Herantis Pharma's current OCF Yield % is -14.32%.

The historical rank and industry rank for Herantis Pharma's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Herantis Pharma was -12144.00%. The lowest was -12144.00%. And the median was -12144.00%.

OHEL:HRTIS's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -63.9
* Ranked among companies with meaningful OCF Margin % only.

Herantis Pharma OCF Margin % Related Terms

Herantis Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Herantis Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Herantis Pharma OCF Margin % Chart

Herantis Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Herantis Pharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OHEL:HRTIS
26GF Score
Herantis Pharma PLC OHEL:HRTIS
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Herantis Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Herantis Pharma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.095/0
= %

Herantis Pharma's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.707/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Herantis Pharma (OHEL:HRTIS) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Herantis Pharma and its competitors. According to the industry distribution chart, Herantis Pharma ranks #999999 out of 953 companies in the Biotechnology industry.
Is Herantis Pharma's OCF Margin % too high?
Herantis Pharma's current OCF Margin % is 0.00%. Based on the distribution chart, Herantis Pharma ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Herantis Pharma has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Herantis Pharma's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Herantis Pharma ranks #999999 out of 953 companies for OCF Margin %. This places Herantis Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Herantis Pharma and its competitors. Herantis Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Herantis Pharma stock overvalued right now?
Herantis Pharma (OHEL:HRTIS) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Herantis Pharma's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Herantis Pharma (OHEL:HRTIS), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Herantis Pharma Business Description

Address Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinsons disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.
26GF Score

Get the complete analysis for OHEL:HRTIS

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.63
Price